share_log

Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Scibetta James S

SEC ·  Nov 4, 2023 04:49
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more